E. Dadachova, E. Revskaya, M. Sesay, R. Howell, G. Thornton, et al., Pre-clinical development of a 188-Re labeled melanin-binding antibody for phase I clinical trial in patients with metastatic melanoma. J Nuclear Medicine. 2008; 49 (Supplement): 327P.